All Stories

  1. Unraveling Potential Candidate Targets Associated with Expression of p16INK4a or p16 Truncated Fragment by Comparative Proteomics Analysis

    Article • Current Proteomics, April 2022, Bentham Science Publishers

    Mohammad Ghahremani, Professor Seyednasser Ostad

  2. Synthesis, evaluation of biological activity, docking and molecular dynamic studies of pyrimidine derivatives

    Article • Letters in Organic Chemistry, July 2020, Bentham Science Publishers

    Professor Massoud Amanlou, Professor Seyednasser Ostad, Shahin Boumi

  3. Design, Synthesis and In Vitro Anti-Cancer Evaluation of Novel Derivatives of 2-(2-Methyl-1,5-diaryl-1H-pyrrol-3-yl)-2-oxo-N-(pyridin-3- yl)acetamide

    Article • Medicinal Chemistry, April 2020, Bentham Science Publishers

    Ebrahim Saeedian Moghadam, Professor Seyednasser Ostad, Professor Saman Hosseinkhani

  4. Synthesis, Anti-proliferative Evaluation, and Molecular Docking Studies of 3-(alkylthio)-5,6-diaryl-1,2,4-triazines as Tubulin Polymerization Inhibitors

    Article • Letters in Drug Design & Discovery, October 2019, Bentham Science Publishers

    Professor Seyednasser Ostad, Professor Massoud Amanlou, Farhad Saravani

  5. Design, Synthesis and Anticancer Evaluation of Novel Series of Indibulin Analogues

    Article • Medicinal Chemistry, April 2019, Bentham Science Publishers

    Professor Seyednasser Ostad

  6. Mesenchymal stem cell exosomes: a two-edged sword in cancer therapy

    Article • International Journal of Nanomedicine, April 2019, Dove Medical Press

    Fatemeh Atyabi, Professor Seyednasser Ostad

  7. Invasion and migration of MDA-MB-231 cells are inhibited by block of AhR and NFAT: role of AhR/NFAT1/β4 integrin signaling

    Article • Journal of Applied Toxicology, October 2018, Wiley

    Professor Seyednasser Ostad

  8. role of antidiabetic drugs on proliferation and survival of mesenchymal stem cells

    Article • Cell Biochemistry and Function, October 2017, Wiley

    Professor Seyednasser Ostad, Elaheh Zafarvahedian

  9. Mesoporous silica nanoparticles functionalized with folic acid/methionine for active targeted delivery of docetaxel

    Article • OncoTargets and Therapy, December 2016, Dove Medical Press

    Professor Massoud Amanlou, Professor Seyednasser Ostad, Farid Dorkoosh

  10. Docetaxel immunonanocarriers as targeted delivery systems for HER2-positive tumor cells: preparation, characterization, and cytotoxicity studies

    Article • International Journal of Nanomedicine, September 2011, Taylor & Francis

    Fatemeh Atyabi, Professor Seyednasser Ostad, Professor Rassoul Dinarvand